Ingolf Cascorbi1. 1. Institute of Clinical and Experimental Pharmacology, University Medical Center Schleswig-Holstein, Kiel. cascorbi@pharmakologie.uni-kiel.de
Abstract
BACKGROUND: Drug interactions can have desired, reduced or unwanted effects. The probability of interactions increases with the number of drugs taken. The high rate of prescribed drugs in elderly patients (65-year-old patients take an average of 5 drugs) increases the likelihood of drug interactions and thus the risk that drugs themselves can be the cause of hospitalization. According to meta-analyses, up to 7% of hospitalizations are drug-related. METHODS: Selective literature review. RESULTS: Drug interactions occur on pharmacodynamic and pharmacokinetic levels. Examples of pharmacodynamic interactions are simultaneous administration of a NSAID and phenprocoumon (additive interaction), or of aspirin and ibuprofen (antagonistic interaction). Pharmacokinetic interactions occur at the levels of absorption (e.g., levothyroxine and neutralizing antacids), elimination (e.g., digoxin and macrolides), and metabolism, as in the competition for cytochrome P450 enzymes (e.g., SSRIs and certain beta-blockers). CONCLUSION: The systematic knowledge of drug interaction, in particular on the level of absorption, elimination, transport and drug metabolism may help to prevent adverse effects. Predicting pharmacodynamic interactions often demands a deeper understanding of the mechanisms of effect. Electronic prescribing systems are helpful.
BACKGROUND: Drug interactions can have desired, reduced or unwanted effects. The probability of interactions increases with the number of drugs taken. The high rate of prescribed drugs in elderly patients (65-year-old patients take an average of 5 drugs) increases the likelihood of drug interactions and thus the risk that drugs themselves can be the cause of hospitalization. According to meta-analyses, up to 7% of hospitalizations are drug-related. METHODS: Selective literature review. RESULTS: Drug interactions occur on pharmacodynamic and pharmacokinetic levels. Examples of pharmacodynamic interactions are simultaneous administration of a NSAID and phenprocoumon (additive interaction), or of aspirin and ibuprofen (antagonistic interaction). Pharmacokinetic interactions occur at the levels of absorption (e.g., levothyroxine and neutralizing antacids), elimination (e.g., digoxin and macrolides), and metabolism, as in the competition for cytochrome P450 enzymes (e.g., SSRIs and certain beta-blockers). CONCLUSION: The systematic knowledge of drug interaction, in particular on the level of absorption, elimination, transport and drug metabolism may help to prevent adverse effects. Predicting pharmacodynamic interactions often demands a deeper understanding of the mechanisms of effect. Electronic prescribing systems are helpful.
Authors: David J Greenblatt; Lisa L von Moltke; Jerold S Harmatz; Gengsheng Chen; James L Weemhoff; Cheng Jen; Charles J Kelley; Barbara W LeDuc; Miguel A Zinny Journal: Clin Pharmacol Ther Date: 2003-08 Impact factor: 6.875
Authors: F Catella-Lawson; M P Reilly; S C Kapoor; A J Cucchiara; S DeMarco; B Tournier; S N Vyas; G A FitzGerald Journal: N Engl J Med Date: 2001-12-20 Impact factor: 91.245
Authors: Alberto Zanchetti; Lennart Hansson; Gastone Leonetti; Karl-Heinz Rahn; Luis Ruilope; Ingrid Warnold; Hans Wedel Journal: J Hypertens Date: 2002-05 Impact factor: 4.844
Authors: Cheri E Klein; Yi-Lin Chiu; Yan Cai; Katrin Beck; Kathryn R King; Sonja J Causemaker; Thao Doan; Hans-Ulrich Esslinger; Thomas J Podsadecki; George J Hanna Journal: J Clin Pharmacol Date: 2008-05 Impact factor: 3.126
Authors: Angelica Mazzolari; Avid M Afzal; Alessandro Pedretti; Bernard Testa; Giulio Vistoli; Andreas Bender Journal: ACS Med Chem Lett Date: 2019-02-12 Impact factor: 4.345
Authors: Erika K S M Leenders; Harm Westdorp; Roger J Brüggemann; Jan Loeffen; Christian Kratz; John Burn; Nicoline Hoogerbrugge; Marjolijn C J Jongmans Journal: Eur J Hum Genet Date: 2018-06-14 Impact factor: 4.246